Lantern Pharma Inc.

Lantern Pharma Inc. is a biopharmaceutical company focused on leveraging artificial intelligence and machine learning to streamline the drug development process. The company's core purpose is to enhance the efficiency and success rate of oncology therapeutics by utilizing a data-driven approach to identify and develop potential drug candidates. Through its proprietary RADR® platform, Lantern Pharma analyzes vast datasets to uncover trends and predict outcomes in cancer treatment, allowing for more personalized and targeted therapies. By integrating cutting-edge technology with biotechnology, the company impacts sectors such as healthcare and technology, fostering innovation in precision medicine. Lantern Pharma plays a significant role in the pharmaceutical industry by potentially reducing the time and cost associated with drug discovery and development, making it a notable player in the realm of biopharmaceuticals. Founded in 2013 and based in Dallas, Texas, Lantern Pharma continues to drive advancements in oncology therapeutics through its pioneering approach.